Breaking News

Fujifilm Diosynth Expands R&D Capabilities

Billingham, UK site adds new equipment, increases workforce

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Fujifilm Diosynth Biotechnologies has completed the first phase of $4.5 million investment in new equipment and labs at its Billingham, UK site. This expansion includes a complete refurbishment of its microbial fermentation lab, including eight new sterilizable 20L Sartorius Stedim Biotech fermenters, and several DASGIP parallel bench-top high throughput units. Also, a new suite of R&D labs has been installed for process development work, with a corresponding increase in the company’s R&amp...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters